Skip to main content

Shearman & Sterling, Fangda Partners and Tian Yuan Law Firm have advised Chinese cancer cell therapy developer JW Therapeutics on its $300 million IPO in Hong Kong, with Davis Polk & Wardwell and Commerce & Finance Law Offices counselling the joint sponsors and underwriters.

JW Therapeutics is a clinical stage cell therapy platform company, founded by Juno Therapeutics and WuXi AppTec in 2016, and focused on developing, manufacturing and commercialising breakthrough cell-based immunotherapies for hematological cancers and solid tumours.

The listing is the latest in the recent flurry of biotech IPOs in Hong Kong. Other recent issuers in the city include Simcere Pharmaceutical Group, JHBP (CY) Holdings and Everest Medicines.

The Shearman team was led by partners Kyungwon (Won) Lee and Max Hua.

 

To contact the editorial team, please email ALBEditor@thomsonreuters.com. 

Related Articles

Deals

CC, DFDL, Bakers, HBS act on $550 mln Cambodia microfinance deal

by Asian Legal Business《亚洲法律杂志》 |

Magic Circle law firm Clifford Chance and DFDL have advised a consortium of investors on the $550 million sale of Cambodian microfinance institution Amret to Taiwan's Bank SinoPac, which was represented by Baker McKenzie Taiwan and local firm HBS Law.

Deals

A&O Shearman guides $1.2 bln Malaysian data centre deal

by Nimitt Dixit |

Global law firm A&O Shearman has advised Malaysian real estate firm Sime Darby Property (SDP) on a $1.2 billion agreement to develop and lease a data centre campus in Malaysia with Google-backed Pearl Computing Malaysia.

Deals

CC, Milbank, Rahmat Lim, Zul Rafique advise on $900 mln M’sia data centre financing

by Asian Legal Business《亚洲法律杂志》 |

Clifford Chance and Rahmat Lim & Partners have represented data centre developer Yondr Group in securing over $900 million in project financing for its hyperscale data centre in Johor, Malaysia. Milbank advised the finance partie